ARMENBE Trademark

Trademark Overview

On Friday, July 18, 2008, a trademark application was filed for ARMENBE with the United States Patent and Trademark Office. The USPTO has given the ARMENBE trademark a serial number of 79057180. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, July 19, 2018. This trademark is owned by Novartis AG. The ARMENBE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
armenbe

General Information

Serial Number79057180
Word MarkARMENBE
Filing DateFriday, July 18, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, July 19, 2018
Registration Number3591553
Registration DateTuesday, March 17, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 30, 2008

Trademark Statements

Goods and ServicesVaccines for human use
Translation of Words in MarkThe wording "armenbe" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 23, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxosmithkline Biologicals S.A.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressBE
Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Friday, February 8, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, February 8, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, April 14, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 23, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, June 23, 2016INVALIDATION PROCESSED
Thursday, June 23, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 23, 2015CANCELLED SECTION 71
Friday, July 3, 2015CHANGE OF OWNER RECEIVED FROM IB
Sunday, April 28, 2013NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 2, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 6, 2009FINAL DISPOSITION NOTICE SENT TO IB
Monday, July 6, 2009FINAL DISPOSITION PROCESSED
Thursday, June 18, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, April 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 26, 2009NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 17, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, December 30, 2008PUBLISHED FOR OPPOSITION
Wednesday, December 10, 2008NOTICE OF PUBLICATION
Tuesday, November 25, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 25, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 25, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 25, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 25, 2008ASSIGNED TO LIE
Friday, November 21, 2008REFUSAL PROCESSED BY IB
Friday, November 14, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 14, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 27, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, October 27, 2008REFUSAL PROCESSED BY MPU
Sunday, October 26, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, October 25, 2008NON-FINAL ACTION WRITTEN
Sunday, October 19, 2008ASSIGNED TO EXAMINER
Friday, September 12, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, September 11, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

armenbe human vaccines